The global Lipid Nanoparticles Market sales is expected to be worth US$ 887.2 million in 2023. Due to rising health concerns about dietary supplements as a result of Covid-19 and increased dietary supplement consumption, the market is estimated to grow at a CAGR of 13.6% between 2023 and 2033, reaching roughly US$ 3,175.5 million by 2033.
One of the major factors expected to contribute to the demand for products such as pharmaceuticals and healthcare, dietary supplements, functional food, functional beverages, cosmetics and personal care, and more is the rapid increase in population in regions such as Asia Pacific, Europe, and North America. The high omega 3 and omega 6 concentration of lipids is the fundamental reason for their widespread use in food and beverage products.
Get Sample PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15992
However, rising global prices of fatty acids and other raw materials, which fluctuate due to the impact of COVID-19 and the ongoing European geopolitical conflict, are impeding global market growth. Furthermore, market participants are concentrating on R&D and developing new advancements in Lipid Nanoparticles technology, which is expected to create lucrative opportunities for the market in the near future.
Factors such as rising demand for medicines due to the high prevalence of cancer and chronic diseases, as well as a growing emphasis on physical well-being, are likely to drive pharmaceutical lipid sales during the analysis period. Pharmaceutical excipients help lipids attain improved functions, such as a longer shelf life, and improve formulation efficacy. Furthermore, rising demand in emerging economies is driving local drug production, which is boosting market sales.
Advances in the composition of lipid nanoparticles for in-vivo systemic distribution of mRNA are also opening up attractive industry opportunities. In order to solve particular medical issues, the leading manufacturing businesses in the lipid nanoparticles market are focusing on creating lipid nanoparticle (LNP)-based medications. Furthermore, they are concentrating on collaborations with government organisations in order to establish new lipid production facilities.
The key companies are extensively investing in product development operations, and their approach to enhancing the business through product launch and acquisition is expected to fuel the global pharmaceutical lipids market’s growth in the approaching years.
Avail Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-15992
Key Takeaways from the Market Study
- By the end of 2022, the global lipid nanoparticles market was worth $781.0 million.
- From 2018 to 2022, market demand increased at a 6.2% CAGR.
- The Solid Lipid Nanoparticles market segment accounts for the majority of the market with a 45% market share.
- With a 43% market share, the Pharmaceutical & Biotechnology category dominates the market by End-User.
- Lipid Nanoparticles sales are predicted to grow at a CAGR of 13.6% between 2023 and 2033.
- The market value of Lipid Nanoparticles is anticipated to reach $3,175.5 million by 2033.
Leading manufacturers are focused on implementing technological advancements to reduce their drug development and manufacturing costs. This, in turn is expected to boost the growth of the Lipid Nanoparticles Market during the forecast period, remarks an FMI analyst.
Competitive Landscape
Prominent players in the Lipid Nanoparticles market are Merck KGaA, Evonik Industries AG, Gattefossé, Precision NanoSystems, IOI Oleo GmbH, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemicals Co. Ltd., Lipoid GmbH, Cargill, Incorporated, BASF SE, Archer Daniels Midland Company, Koninklijke DSM N.V., Kerry Group plc., Nordic Naturals, Inc., Clover Corporation, Croda International plc., Lipoid Kosmetik AG, and Omega Protein Corporation, among others.
Recent Developments:
- In October 2022, Polypeptide Therapeutic Solutions (PTS), key player in the manufacturing and development of polyamino-acid based delivery systems expanded its drug delivery capabilities including novel nanoparticle formulation and functional lipid excipients.
- In September 2022, National Institute of Allergy and Infectious Diseases awarded USD 13.8 million contract to the University of California for conducting immune profiling of lipid nanoparticles to study their role in increasing vaccine protective responses.
Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-15992
Key Segments Covered in the Lipid Nanoparticles Industry Analysis
Lipid Nanoparticles Market by Type:
- Solid Lipid Nanoparticles (SLNs)
- Nanostructured Lipid Carriers (NLCs)
- Others
Lipid Nanoparticles Market by Application:
- Therapeutics
- Research
Lipid Nanoparticles Market by End-User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs